Titan Pharmaceuticals, Inc. Proceeds from Long-Term Debt Issued
Titan Pharmaceuticals, Inc. reported Proceeds from Long-Term Debt Issued of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2022-03-25
- Titan Pharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-12-31 was $0.00.
- Titan Pharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2021-09-30 was $0.00.
- Titan Pharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-12-31 was $0.00.
- Titan Pharmaceuticals, Inc. proceeds from issuance of long-term debt for the quarter ending 2020-09-30 was $0.00.
- Titan Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Titan Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2020 was $654.00K.
- Titan Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2019 was $0.00.
- Titan Pharmaceuticals, Inc. proceeds from issuance of long-term debt for fiscal 2013 was $0.00.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $0.00 derived: sum of 2 quarters · filed 2022-03-25 | $0.00 10-K · filed 2022-03-25 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $0.00 derived: sum of 2 quarters · filed 2022-03-25 | $654.00K 10-K · filed 2022-03-25 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $654.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $654.00K 10-Q · filed 2021-08-16 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 10-K · filed 2021-03-31 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 | |||
| 2018-09-30 | $640.00K 10-Q · filed 2018-11-14 | |||
| 2017-09-30 | $6.72M 10-Q · filed 2018-11-14 | |||
| 2016-09-30 | $0.00 10-Q · filed 2017-11-09 | |||
| 2013-12-31 | $0.00 10-K · filed 2014-03-31 | |||
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 | |||
| 2012-06-30 | $0.00 10-Q · filed 2012-08-09 | |||
| 2011-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$3.00M derived: sum of 2 quarters · filed 2014-03-31 | $16.50M 10-K · filed 2014-03-31 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $19.50M 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | $19.50M 10-Q · filed 2012-08-09 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $5.00M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $5.00M 10-Q · filed 2011-11-14 | |||
| 2009-12-31 | $3.00M 10-K · filed 2012-03-15 |